EMK PHARM: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
EMK PHARM
Largest movements
- Tangible fixed assets -€13,551
down €13,551 (-35.1%), from €38,659 to €25,108
- Receivables within one year +€12,148
up €12,148 (+40.8%), from €29,759 to €41,907
of which Other amounts receivable: +€16,972
- Cash -€1,547
down €1,547 (-55.9%), from €2,766 to €1,219
mainly Contributions, distributions and other (-€20,000) and Receivables within one year (-€12,148)
- Other debts +€20,000
up €20,000, from €0 to €20,000
- Profit (loss) carried forward -€13,705
down €13,705 (-76.1%), from €18,000 to €4,295
- Debts after one year -€9,773
down €9,773 (-40.0%), from €24,433 to €14,660
- Gross operating margin +€5,089
up €5,089 (+25.4%), from €20,048 to €25,138
- Depreciation -€1,576
down €1,576 (-10.4%), from €15,127 to €13,551
- Taxes +€1,232
up €1,232 (+33.7%), from €3,656 to €4,888
- Other operating charges -€585
down €585 (-100.0%), from €585 to €0
- Financial charges +€256
up €256 (+172.6%), from €148 to €404
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €73,379 | €70,362 | -€3,018 | -4.1% |
| Fixed assets | 21/28 | €38,909 | €25,358 | -€13,551 | -34.8% |
| Tangible fixed assets | 22/27 | €38,659 | €25,108 | -€13,551 | -35.1% |
| Furniture and vehicles | 24 | €38,659 | €25,108 | -€13,551 | -35.1% |
| Financial fixed assets | 28 | €250 | €250 | = | 0.0% |
| Current assets | 29/58 | €34,471 | €45,004 | +€10,533 | +30.6% |
| Amounts receivable within one year | 40/41 | €29,759 | €41,907 | +€12,148 | +40.8% |
| Trade receivables | 40 | €11,515 | €6,690 | -€4,825 | -41.9% |
| Other amounts receivable | 41 | €18,244 | €35,217 | +€16,972 | +93.0% |
| Cash at bank and in hand | 54/58 | €2,766 | €1,219 | -€1,547 | -55.9% |
| Deferred charges and accrued income | 490/1 | €1,946 | €1,878 | -€68 | -3.5% |
| Total equity and liabilities | 10/49 | €73,379 | €70,362 | -€3,018 | -4.1% |
| Equity | 10/15 | €18,000 | €4,295 | -€13,705 | -76.1% |
| Profit (loss) carried forward | 14 | €18,000 | €4,295 | -€13,705 | -76.1% |
| Amounts payable | 17/49 | €55,380 | €66,067 | +€10,687 | +19.3% |
| Amounts payable after more than one year | 17 | €24,433 | €14,660 | -€9,773 | -40.0% |
| Financial debts | 170/4 | €24,433 | €14,660 | -€9,773 | -40.0% |
| Amounts payable within one year | 42/48 | €30,947 | €51,407 | +€20,460 | +66.1% |
| Current portion of amounts payable after more than one year | 42 | €9,773 | €9,773 | = | 0.0% |
| Trade debts | 44 | €1,964 | €2,544 | +€581 | +29.6% |
| Suppliers | 440/4 | €1,964 | €2,544 | +€581 | +29.6% |
| Taxes, remuneration and social security | 45 | €19,210 | €19,090 | -€120 | -0.6% |
| Taxes | 450/3 | €14,852 | €14,450 | -€402 | -2.7% |
| Remuneration and social security | 454/9 | €4,358 | €4,640 | +€282 | +6.5% |
| Other amounts payable | 47/48 | €0 | €20,000 | +€20,000 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €15,127 | €13,551 | -€1,576 | -10.4% |
| Other operating charges | 640/8 | €585 | €0 | -€585 | -100.0% |
| Gross operating margin | 9900 | €20,048 | €25,138 | +€5,089 | +25.4% |
| Operating profit (loss) | 9901 | €4,336 | €11,587 | +€7,251 | +167.2% |
| Financial income | 75/76B | €0 | €0 | -€0 | -100.0% |
| Recurring financial income | 75 | €0 | €0 | -€0 | -100.0% |
| Financial charges | 65/66B | €148 | €404 | +€256 | +172.6% |
| Recurring financial charges | 65 | €148 | €404 | +€256 | +172.6% |
| Profit (loss) for the period before taxes | 9903 | €4,188 | €11,183 | +€6,995 | +167.0% |
| Income taxes | 67/77 | €3,656 | €4,888 | +€1,232 | +33.7% |
| Profit (loss) for the period | 9904 | €532 | €6,295 | +€5,763 | +1083.5% |
| Profit (loss) for the period to be appropriated | 9905 | €532 | €6,295 | +€5,763 | +1083.5% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 10 October 2026 via checked.be.